Marco Caminati

4.7k total citations
146 papers, 2.1k citations indexed

About

Marco Caminati is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Marco Caminati has authored 146 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Physiology, 68 papers in Pulmonary and Respiratory Medicine and 57 papers in Immunology and Allergy. Recurrent topics in Marco Caminati's work include Asthma and respiratory diseases (95 papers), Allergic Rhinitis and Sensitization (51 papers) and Respiratory and Cough-Related Research (38 papers). Marco Caminati is often cited by papers focused on Asthma and respiratory diseases (95 papers), Allergic Rhinitis and Sensitization (51 papers) and Respiratory and Cough-Related Research (38 papers). Marco Caminati collaborates with scholars based in Italy, United States and France. Marco Caminati's co-authors include Gianenrico Senna, Giorgio Walter Canonica, Diego Bagnasco, Duy Le Pham, Andrea Vianello, Gabriella Guarnieri, Erminia Ridolo, Enrico Heffler, Claudio Micheletto and Michele Schiappoli and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and BMC Public Health.

In The Last Decade

Marco Caminati

137 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Caminati Italy 25 1.2k 828 712 294 270 146 2.1k
Diego Bagnasco Italy 23 1.3k 1.1× 823 1.0× 465 0.7× 421 1.4× 287 1.1× 103 1.8k
Luís Taborda‐Barata Portugal 21 1.0k 0.9× 327 0.4× 636 0.9× 657 2.2× 187 0.7× 87 1.8k
Stefano Del Giacco Italy 20 548 0.5× 366 0.4× 369 0.5× 207 0.7× 101 0.4× 79 1.5k
Silvia Caimmi Italy 24 509 0.4× 303 0.4× 523 0.7× 146 0.5× 226 0.8× 89 1.6k
Michela Silvestri Italy 30 1.5k 1.3× 1.4k 1.7× 552 0.8× 280 1.0× 362 1.3× 130 2.8k
Kerstin Gerhold Germany 20 709 0.6× 202 0.2× 367 0.5× 414 1.4× 99 0.4× 44 1.8k
Mahboobeh Mahdavinia United States 25 691 0.6× 352 0.4× 836 1.2× 91 0.3× 574 2.1× 102 2.2k
Luís Miguel Borrego Portugal 23 615 0.5× 261 0.3× 742 1.0× 281 1.0× 233 0.9× 99 1.7k
V J Lund United Kingdom 26 1.4k 1.2× 607 0.7× 1.7k 2.4× 115 0.4× 1.9k 7.0× 55 4.1k
Mona‐Rita Yacoub Italy 17 331 0.3× 196 0.2× 307 0.4× 137 0.5× 186 0.7× 64 1.2k

Countries citing papers authored by Marco Caminati

Since Specialization
Citations

This map shows the geographic impact of Marco Caminati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Caminati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Caminati more than expected).

Fields of papers citing papers by Marco Caminati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Caminati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Caminati. The network helps show where Marco Caminati may publish in the future.

Co-authorship network of co-authors of Marco Caminati

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Caminati. A scholar is included among the top collaborators of Marco Caminati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Caminati. Marco Caminati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vianello, Andrea, Luciano Corda, Paolo Baderna, et al.. (2025). Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency. PubMed. 2(1). 53–55.
2.
Bagnasco, Diego, Luisa Brussino, Stefania Nicola, et al.. (2025). Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab. Journal of Personalized Medicine. 15(2). 43–43.
3.
Argentino, Giuseppe, et al.. (2025). Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation. Cells. 14(7). 542–542. 2 indexed citations
4.
Feleszko, Wojciech, Marco Caminati, Sebastian L. Johnston, et al.. (2025). Effect of tezepelumab on asthma exacerbations co-occurring with infection-attributed acute respiratory illnesses. Annals of Allergy Asthma & Immunology. 136(1). 61–65.e1.
5.
Caminati, Marco, Andrea Portacci, Claudio Montuori, et al.. (2025). When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications. Expert Review of Respiratory Medicine. 1–11.
6.
Corso, Eugenio De, et al.. (2025). Clinical management of dupilumab-induced blood eosinophilia in CRSwNP: a practical algorithm. Rhinology Journal. 0(0). 0–0. 2 indexed citations
7.
Caminati, Marco, et al.. (2024). Diagnosis, management and therapeutic options for eosinophilic esophagitis. Current Opinion in Allergy and Clinical Immunology. 24(3). 122–128. 2 indexed citations
8.
Canani, Roberto Berni, Marco Caminati, Laura R. Carucci, & Ibon Eguíluz‐Gracia. (2024). Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases. Allergy. 79(6). 1485–1500. 33 indexed citations
9.
Caminati, Marco, Alessandro Marcon, Gianenrico Senna, et al.. (2024). Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort. World Allergy Organization Journal. 17(8). 100941–100941. 1 indexed citations
10.
Caminati, Marco, Alessandro Vatrella, Paola Rogliani, et al.. (2024). Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles. Respiratory Research. 25(1). 367–367. 6 indexed citations
11.
Caminati, Marco, Eugenio De Corso, Giancarlo Ottaviano, et al.. (2023). Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps. Current Allergy and Asthma Reports. 24(1). 11–23. 10 indexed citations
12.
Olivieri, Bianca, Lucia De Franceschi, Nicola Martinelli, et al.. (2023). Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach. Journal of Clinical Medicine. 12(6). 2294–2294. 3 indexed citations
13.
Caminati, Marco, Alessandro Marcon, Diego Bagnasco, et al.. (2023). Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective. Journal of Clinical Medicine. 12(5). 1836–1836. 6 indexed citations
14.
Bleecker, Eugene R., Mona Al‐Ahmad, Leif Bjermer, et al.. (2022). Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group. World Allergy Organization Journal. 15(12). 100726–100726. 36 indexed citations
15.
Caruso, Cristiano, Stefania Colantuono, Gabriele Ciasca, et al.. (2022). Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity. Allergy. 78(1). 131–140. 14 indexed citations
16.
Vitte, Joana, Moïse Michel, Andreï Malinovschi, et al.. (2022). Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy. Allergy. 77(11). 3199–3216. 29 indexed citations
17.
Marcon, Alessandro, Veronica Batani, Marco Caminati, et al.. (2022). Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia. Annals of Medicine. 54(1). 869–874. 6 indexed citations
18.
Caminati, Marco, Erminia Ridolo, Massimo Landi, et al.. (2019). Use of complementary medicine among patients with allergic rhinitis: an Italian nationwide survey. Clinical and Molecular Allergy. 17(1). 2–2. 11 indexed citations
19.
Kolkhir, Pavel, Dmitry Pogorelov, Razvigor Darlenski, et al.. (2018). Management of chronic spontaneous urticaria: a worldwide perspective. World Allergy Organization Journal. 11(1). 14–14. 30 indexed citations
20.
Yacoub, Mona‐Rita, Giselda Colombo, Francesco Marcucci, et al.. (2012). Effects of Sublingual Immunotherapy on Allergic Inflammation: An Update. Inflammation & Allergy - Drug Targets. 11(4). 285–291. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diego Bagnasco Breakdown of academic impact, for papers by Luís Taborda‐Barata Breakdown of academic impact, for papers by Stefano Del Giacco Breakdown of academic impact, for papers by Silvia Caimmi Breakdown of academic impact, for papers by Michela Silvestri Breakdown of academic impact, for papers by Kerstin Gerhold Breakdown of academic impact, for papers by Mahboobeh Mahdavinia Breakdown of academic impact, for papers by Luís Miguel Borrego Breakdown of academic impact, for papers by V J Lund Breakdown of academic impact, for papers by Mona‐Rita Yacoub
Rankless by CCL
2026